Navigation Links
URAC Announces Four More Companies in Process to Earn New Pharmacy Quality Management Accreditations

WASHINGTON, Feb. 11 /PRNewswire-USNewswire/ -- URAC announced today that four more organizations are on track to earn its accreditation for Pharmacy Benefit Management and/or Drug Therapy Management, a range of pharmacy management services designed to optimize therapeutic outcomes for individual consumers.

(Logo: )

URAC is the Washington, D.C.-based independent accreditor which offers more than 20 accreditation and certification programs along the continuum of care. Currently URAC accredits more than 400 health care management organizations operating in all 50 states.

URAC's Pharmacy Quality Management Program standards, developed concurrently with the Pharmacy Benefit Management standards and released in 2007, are designed to help organizations drive appropriate therapeutic outcomes for consumers with a clear focus on patient safety, outcomes measurement and quality improvement. They address a broad range of functions, such as development of clinical policies using evidence-based medicine; patient communication regarding medication use; and promoting consumer rights, shared decision making and education.

"These companies are at the forefront of this industry sector, and have stepped out voluntarily to seek a rigorous evaluation of their operations," said Alan P. Spielman, URAC's president and CEO. "Accreditation is a validation that companies are committed to quality and are willing to be accountable throughout their operations."

URAC's Pharmacy Quality Management Accreditation Programs are applicable to a broad range of health management organizations--pharmacy benefit management companies, or care management companies with oversight of a clinical Drug Therapy Management program, such as case management or disease management organizations. The companies that are In-Process are:

Diplomat Specialty Pharmacy (Drug Therapy Management and Disease Management accreditations); MaxorPlus, Ltd. (Pharmacy Benefit Management and Drug Therapy Management accreditations); MemberHealth, LLC, a subsidiary of Universal American Corp. (Pharmacy Benefit Management and Drug Therapy Management accreditations); and UnitedHealth Pharmaceutical Solutions, a division of United HealthCare Services, Inc. (Pharmacy Benefit Management and Drug Therapy Management accreditations)

"The emphasis on patient safety and continuous quality improvement these companies must demonstrate to become accredited sets them apart as leaders in the field," said Christine G. Leyden, RN, MSN, URAC's chief accreditation officer. "Consumers and purchasers can be assured the URAC seal means accredited organizations demonstrate ongoing accountability and a dedicated focus on quality."

For more information about URAC's Pharmacy Quality Management Accreditation Programs go to

About URAC

URAC, an independent, nonprofit organization, is well-known as a leader in promoting health care quality through its accreditation and education programs. URAC offers a wide range of quality benchmarking programs and services that keep pace with the rapid changes in the health care system, and provide a symbol of excellence for organizations to validate their commitment to quality and accountability. Through its broad-based governance structure and an inclusive standards development process, URAC ensures that all stakeholders are represented in establishing meaningful quality measures for the entire health care industry. For more information, visit

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories
Post Your Comments:
(Date:11/29/2015)... ... ... Effective immediately, every single IguanaMed scrub style will be available at Target via ... “Buy One Scrub Set, Get the 2nd Scrub Set 50% Off” for a limited ... price. , IguanaMed’s mission is to outfit every healer around the world ...
(Date:11/28/2015)... , ... November 28, 2015 , ... Safe storage for ... of two inventors, one from Lakewood, New Jersey and the other from Bradley Beach, ... patent-pending PROTECTOR to save the expense of having to replace NuvaRings more often than ...
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back again ... choose from, the possibilities are endless. Users have full control over angle of view, ... masking effects, users are sure to get heads to turn. , ProPanel: Pulse offers ...
(Date:11/27/2015)... ... 27, 2015 , ... According to an article published November 6th ... the University of British Columbia suggested that laws requiring bicyclists to wear helmets may ... part of the reason for the controversial conclusion is that, while helmets have certainly ...
(Date:11/27/2015)... , ... November 27, 2015 , ... A team of ... ways to treat it. Surviving Mesothelioma has just posted the findings on the website. ... Hospital Zurich analyzed the cases of 136 mesothelioma patients who were treated with chemotherapy ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 2015 ) ... "Radioimmunoassay Market by Type (Reagents & Kits, ... Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), ... report to their offering. --> ... of the "Radioimmunoassay Market by Type ...
(Date:11/25/2015)... 2015 ... "Global Brain Monitoring Devices Market 2015-2019" ... ) has announced the addition ... Market 2015-2019" report to their offering. ... ) has announced the addition of ...
(Date:11/25/2015)... THOUSAND OAKS, Calif. , Nov. 25, 2015 /PRNewswire/ ... of a Biologics License Application (BLA) with ... Administration (FDA) for ABP 501, a biosimilar candidate to ... the first adalimumab biosimilar application submitted to the FDA ... biosimilar pathway. Sean E. Harper , M.D., ...
Breaking Medicine Technology: